Evaluation of Patient's Knowledge of Their NACO Treatment

Status Completed

Clinical Trial Summary

More than one million of patient receive anti vitamine K treatment which is the main cause of hospitalization. About 50 000 patient receive direct oral anticoagulant .

The aim is to evaluate the patient's level of knowledge about their anticoagulant treatment and specially about the side effect

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Anticoagulant

Clinical Trial Details

NCT number	NCT03323320
Study type	Observational
Source	Groupe Hospitalier Paris Saint Joseph
Contact
Status	Completed
Phase	N/A
Start date	December 5, 2016
Completion date	November 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04010955` - Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
Recruiting	`NCT04673695` - A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344	Phase 1
Completed	`NCT03893591` - A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity
Completed	`NCT03895502` - Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study	Phase 4
Completed	`NCT03154489` - Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care	N/A
Completed	`NCT04305821` - Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thrombotics
Recruiting	`NCT06020560` - Study of Low Molecular Weight Heparins	Phase 4
Not yet recruiting	`NCT05788900` - Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration	Phase 1
Not yet recruiting	`NCT05788913` - Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration	Phase 1
Terminated	`NCT03172546` - Determinants of Oral Anticoagulants' Activity
Not yet recruiting	`NCT04592822` - A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition	Phase 1
Recruiting	`NCT03772457` - Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban
Recruiting	`NCT04257487` - Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)	Phase 3
Completed	`NCT04272723` - Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians
Recruiting	`NCT04867200` - A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers	Phase 1